DSP Healthcare Fund - Growth - Regular Plan

Other Plans and Options
  • 1.17 %Nav, as on 27-09-2023

  • Previous Nav

  • Net Change on 27-09-2023

  • PersonalFN Rating

  • Assets (Cr.)

  • Expense Ratio

Fund Overview Growth | Regular Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

The primary investment objective of the scheme is to seek to generate consistent returns bypredominantly investing in equity and equity related securities of pharmaceutical and healthcarecompanies.

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
NIFTY 50 - TRI N/A N/A N/A N/A N/A N/A
S&P BSE Health Care - TRI 0.09 9.22 22.77 12.76 13.93 14.13

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Scheme Name Launch Date Ratings 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Expense Ratio (%) Assets (Cr.)
Nippon India Pharma Fund-Growth Plan-Growth Jun 05, 2004 26.14 15.88 16.72 1.89 5,544.92
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Cumulative Option Jul 13, 2018 28.29 15.10 17.80 2.00 3,174.41
SBI HEALTHCARE OPPORTUNITIES FUND - REGULAR PLAN -GROWTH Jul 14, 1999 30.28 17.11 16.77 2.09 2,032.95
Mirae Asset Healthcare Fund -Regular Growth Jul 02, 2018 20.22 14.68 18.87 2.05 1,812.41
UTI Healthcare Fund - Regular Plan - Growth Option Aug 01, 2005 25.40 13.02 15.17 2.38 776.06

Fund Holdings as on 31-August-2023

  • Sun Pharmaceutical Industries Limited

  • Cipla Limited

  • Lupin Limited

  • Suven Pharmaceuticals Limited

  • IPCA Laboratories Limited

  • Alembic Pharmaceuticals Limited

  • Apollo Hospitals Enterprise Limited

  • Procter & Gamble Health Limited

  • Alkem Laboratories Limited

  • Concord Biotech Limited

  • TREPS / Reverse Repo Investments / Corporate Debt Repo

  • Vijaya Diagnostic Centre Limited

  • Intuitive Surgical Inc

  • Zydus Lifesciences Limited

  • Aarti Drugs Limited

  • Indoco Remedies Limited

  • Mankind Pharma Limited

  • ICICI Lombard General Insurance Company Limited

  • Kovai Medical Center and Hospital Limited

  • Globus Medical Inc

  • Abbott Laboratories

  • Taro Pharmaceutical Industries Limited

  • Unichem Laboratories Limited

  • Global X Funds - Global X Genomics & Biotechnology ETF

  • Medplus Health Services Limited

  • Illumina Inc

  • Pfizer Limited

  • Net Receivables/Payables

View More

  • Pharmaceuticals & Drugs

  • Hospital & Healthcare Services

  • Miscellaneous

  • Insurance

View More

  • Cash

  • Equity

  • MFU

View More

About DSP Healthcare Fund

Scheme Analysis

DSP Healthcare Fund is a Equity - Sectoral Fund - Pharma & Health Care fund and belongs to DSP Mutual Fund. It was launched on 30-Nov-2018 and currently has an AUM of ₹1,645.58 crore. DSP Healthcare Fund is benchmarked against NIFTY 50 - TRI as primary index and S&P BSE Health Care - TRI as secondary index.

The NAV of DSP Healthcare Fund ended up ₹0.3(1.17%)yesterday to ₹25.84.

Among its top 3 holdings the fund has exposure to Sun Pharmaceutical Industries Limited, and

The DSP Healthcare Fund is managed by Jay Kothari and Chirag Dagli.

Fund House Contact

Mafatlal Centre, 10th Floor, Nariman Point, Mumbai - 400 021

+91 (22) 66578000
+91 (22) 66578181